Labopharm Inc. (DDSS) is “One to Watch
Headquartered in Laval, Quebec, Canada, Labopharm Inc. is optimizing the performance of existing small molecule drugs using their proprietary controlled-release technologies. The Company's lead product is being commercially launched in key markets globally. This product is a unique once-daily formulation of tramadol. Their second product, a novel formulation of trazodone for the treatment of major depressive disorder, is under regulatory review by the FDA. The Company also has a pipeline of follow-on products in both pre-clinical and clinical development. Their corporate mission is to become an integrated, international, specialty pharmaceutical company with the capability to internally develop and commercialize their…